Literature DB >> 27160771

Pill Burden Influences the Association Between Time-Based Prospective Memory and Antiretroviral Therapy Adherence in Younger But Not Older HIV-Infected Adults.

David P Sheppard, Erica Weber, Kaitlin B Casaletto, Gunes Avci, Steven Paul Woods.   

Abstract

Prospective memory (PM) is associated with antiretroviral (ARV) adherence in HIV, but little is known about how pill burden and age might affect this association. One hundred seventeen older (≥50 years) and 82 younger (<50 years) HIV-infected adults were administered a measure of PM in the laboratory and subsequently were monitored for ARV adherence for 30 days using the Medication Event Monitoring System. In the older group, better time-based PM performance was associated with higher likelihood of adherence, irrespective of pill burden. Within the younger sample, time-based PM was positively related to adherence only in participants with lower pill burdens. Younger HIV-infected individuals with higher pill burdens may overcome the normal effects of time-based PM on adherence through compensatory medication-taking strategies, whereas suboptimal use of these strategies by younger HIV-infected individuals with lower pill burdens may heighten their risk of ARV nonadherence secondary to deficits in time-based PM.
Copyright © 2016 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; adherence; aging; pill burden; prospective memory

Mesh:

Substances:

Year:  2016        PMID: 27160771      PMCID: PMC4976032          DOI: 10.1016/j.jana.2016.03.006

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  37 in total

1.  Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.

Authors:  Jean B Nachega; Alice J Hsu; Olalekan A Uthman; Anne Spinewine; Paul A Pham
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

2.  Is prospective memory a dissociable cognitive function in HIV infection?

Authors:  Saurabh Gupta; Steven Paul Woods; Erica Weber; Matthew S Dawson; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2010-04-27       Impact factor: 2.475

3.  Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease.

Authors:  Steven Paul Woods; Erin E Morgan; Jennifer Marquie-Beck; Catherine L Carey; Igor Grant; Scott L Letendre
Journal:  Cogn Behav Neurol       Date:  2006-12       Impact factor: 1.600

4.  The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection.

Authors:  Steven Paul Woods; Matthew S Dawson; Erica Weber; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2009-09-17       Impact factor: 2.475

Review 5.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

Authors:  David R Bangsberg
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

6.  The impact of neuropsychological performance on everyday functioning between older and younger adults with and without HIV.

Authors:  David E Vance; Pariya L Fazeli; C Ann Gakumo
Journal:  J Assoc Nurses AIDS Care       Date:  2012-09-01       Impact factor: 1.354

7.  Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?

Authors:  Steven Paul Woods; Lisa M Moran; Catherine L Carey; Matthew S Dawson; Jennifer E Iudicello; Sarah Gibson; Igor Grant; J Hampton Atkinson
Journal:  Arch Clin Neuropsychol       Date:  2008-02-19       Impact factor: 2.813

8.  Psychometric characteristics of the memory for intentions screening test.

Authors:  Steven Paul Woods; Lisa M Moran; Matthew S Dawson; Catherine L Carey; Igor Grant
Journal:  Clin Neuropsychol       Date:  2008-09       Impact factor: 3.535

9.  Cognitive Impairment and Medication Complexity in Community-Living Older Adults: The Health, Aging and Body Composition Study.

Authors:  David Sh Lee; Nathalie de Rekeneire; Joseph T Hanlon; Thomas M Gill; Douglas C Bauer; Bernd Meibohm; Tamara B Harris; Sean M Jeffery
Journal:  J Pharm Technol       Date:  2012-07-01

10.  Aging, neurocognition, and medication adherence in HIV infection.

Authors:  Mark L Ettenhofer; Charles H Hinkin; Steven A Castellon; Ramani Durvasula; Jodi Ullman; Mona Lam; Hector Myers; Matthew J Wright; Jessica Foley
Journal:  Am J Geriatr Psychiatry       Date:  2009-04       Impact factor: 4.105

View more
  5 in total

1.  A systematic review of prospective memory in HIV disease: from the laboratory to daily life.

Authors:  Gunes Avci; David P Sheppard; Savanna M Tierney; Victoria M Kordovski; Kelli L Sullivan; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2017-09-27       Impact factor: 3.535

2.  Factor Structure of the Memory for Intentions Test (MIsT): A Conceptual Replication in Older Adults and People with HIV Disease.

Authors:  Kelli L Sullivan; Matthew W Gallagher; Romola S Bucks; Michael Weinborn; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2022-08-05       Impact factor: 2.283

3.  Subjective cognitive decline disrupts aspects of prospective memory in older adults with HIV disease.

Authors:  Jennifer L Thompson; David P Sheppard; Anastasia Matchanova; Erin E Morgan; Shayne Loft; Steven Paul Woods
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2022-04-12

4.  The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.

Authors:  Mi Young Ahn; Awachana Jiamsakul; Suwimon Khusuwan; Vohith Khol; Thuy T Pham; Romanee Chaiwarith; Anchalee Avihingsanon; Nagalingeswaran Kumarasamy; Wing Wei Wong; Sasisopin Kiertiburanakul; Sanjay Pujari; Kinh V Nguyen; Man Po Lee; Adeeba Kamarulzaman; Fujie Zhang; Rossana Ditangco; Tuti P Merati; Evy Yunihastuti; Oon Tek Ng; Benedict L H Sim; Junko Tanuma; Winai Ratanasuwan; Jeremy Ross; Jun Yong Choi
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

5.  Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.

Authors:  Adriana Ammassari; Wolfgang Stöhr; Andrea Antinori; Jean-Michel Molina; Christine Schwimmer; Pere Domingo; Anders Thalme; Massimo Di Pietro; Cedrick Wallet; Anton Pozniak; Laura Richert; François Raffi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.